Journal of Neuro-Oncology

, Volume 98, Issue 2, pp 265–270 | Cite as

Tumor control and hearing preservation after Gamma Knife radiosurgery for vestibular schwannomas in neurofibromatosis type 2

  • Manish Singh Sharma
  • Rakesh Singh
  • Shashank S. Kale
  • Deepak Agrawal
  • Bhawani Shankar Sharma
  • Ashok Kumar Mahapatra
Clinical Study/Patient Study


To analyze the effect of Gamma Knife radiosurgery (GKS) on tumor control and hearing preservation rates in patients with vestibular schwannomas (VS) in a setting of neurofibromatosis type 2 (NF 2), a retrospective study was carried out at a tertiary-level referral Gamma Knife unit. Dose plans, pre- and postoperative radiology, and follow-up clinical records of patients with NF 2 who had undergone GKS for VS using a Leksell Gamma Knife (Elekta Instruments AB, Stockholm, Sweden) model B unit from 1997 to 2008 were reviewed. Thirty patients with 54 VS underwent GKS. The average age of the cohort was 29 years (range 10–56 years). Twenty-four patients had bilateral VS. The commonest clinical presentation was hearing loss and tinnitus. Primary GKS was given to 36 tumors, while 18 tumors received it as an adjunct to surgery. Average tumor size was 3.7 cc (range 0.1–13.3 cc). A median 12 Gy prescription dose (range 10–15 Gy) was administered at the 50% isodose (range 42–50%) to cover on average 91.5% of the tumor. Eighteen patients were available for clinical, 14 patients for radiological, and 5 patients (with useful hearing) for audiometric follow-up at an average of 26.6 months. The tumor control rate was 87.5% in this series (33.3% tumor regression), while hearing preservation was noted in 66.7% of cases. One patient developed worsening of facial function. GKS for VS provides satisfactory tumor control and hearing preservation in patients with NF 2. Long-term follow-up will determine future recommendations.


Bilateral Gamma Knife Neurofibromatosis type 2 Outcome Stereotactic radiosurgery Vestibular schwannoma 


Conflict of interest statement



  1. 1.
    Evans DG, Baser ME, O’Reilly B, Rowe J, Gleeson M, Saeed S et al (2005) Management of the patient and family with neurofibromatosis 2: a consensus conference statement. Br J Neurosurg 19:5–12CrossRefPubMedGoogle Scholar
  2. 2.
    Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51–57CrossRefPubMedGoogle Scholar
  3. 3.
    National Institutes of Health (1988) Consensus development conference: neurofibromatosis conference statement. Arch Neurol 45:575–578Google Scholar
  4. 4.
    Hasegawa T, Fujitani S, Katsumata S, Kida Y, Yoshimoto M, Koike J (2005) Stereotactic radiosurgery for vestibular schwannomas: analysis of 317 patients followed more than 5 years. Neurosurgery 57:257–265CrossRefPubMedGoogle Scholar
  5. 5.
    Lunsford LD, Niranjan A, Flickinger JC, Maitz A, Kondziolka D (2005) Radiosurgery of vestibular schwannomas: summary of experience in 829 cases. J Neurosurg 102:195–199CrossRefPubMedGoogle Scholar
  6. 6.
    Pollock BE, Driscoll CL, Foote RL, Link MJ, Gorman DA, Bauch CD et al (2006) Patient outcomes after vestibular schwannoma management: a prospective comparison of microsurgical resection and stereotactic radiosurgery. Neurosurgery 59:77–85CrossRefPubMedGoogle Scholar
  7. 7.
    Kida Y, Kobayashi T, Tanaka T, Mori Y (2000) Radiosurgery for bilateral neurinomas associated with neurofibromatosis type 2. Surg Neurol 53:383–390CrossRefPubMedGoogle Scholar
  8. 8.
    Mathieu D, Kondziolka D, Flickinger JC, Niranjan A, Williamson R, Martin JJ et al (2007) Stereotactic radiosurgery for vestibular schwannomas in patients with neurofibromatosis type 2: an analysis of tumor control, complications, and hearing preservation rates. Neurosurgery 60:460–468PubMedGoogle Scholar
  9. 9.
    Phi JH, Kim DG, Chung HT, Lee J, Paek SH, Jung HW (2009) Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation. Cancer 115:390–398CrossRefPubMedGoogle Scholar
  10. 10.
    Roche PH, Regis J, Pellet W, Thomassin JM, Gregoire R, Dufour H et al (2000) Neurofibromatosis type 2: preliminary results of Gamma Knife radiosurgery of vestibular schwannomas. Neurochirurgie 46:339–354 (Fr)PubMedGoogle Scholar
  11. 11.
    Rowe JG, Radatz MW, Walton L, Soanes T, Rodgers J, Kemeny AA (2003) Clinical experience with Gamma Knife stereotactic radiosurgery in the management of vestibular schwannomas secondary to type 2 neurofibromatosis. J Neurol Neurosurg Psychiatry 74:1288–1293CrossRefPubMedGoogle Scholar
  12. 12.
    Clark JG (1981) Uses and abuses of hearing loss classification. ASHA 23:493–500PubMedGoogle Scholar
  13. 13.
    Antinheimo J, Sankila R, Carpén O, Pukkala E, Sainio M, Jääskeläinen J (2000) Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas. Neurology 54:71–76PubMedGoogle Scholar
  14. 14.
    Evans DG, Huson SM, Donnai D, Neary W, Blair V, Teare D et al (1992) A genetic study of type 2 neurofibromatosis in the United Kingdom, I: prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet 29:841–846CrossRefPubMedGoogle Scholar
  15. 15.
    Samii M, Matthies C, Tatagiba M (1997) Management of vestibular schwannomas (acoustic neuromas): auditory and facial nerve function after resection of 120 vestibular schwannomas in patients with neurofibromatosis 2. Neurosurgery 40:696–706CrossRefPubMedGoogle Scholar
  16. 16.
    Nitta T, Sato K (1995) A clinical study of 21 patients with neurofibromatosis I and II. No Shinkei Geka 23:131–135 (Jpn)PubMedGoogle Scholar
  17. 17.
    Perks JR, St George EJ, El Hamri K, Blackburn P, Plowman PN (2003) Stereotactic radiosurgery XVI: isodosimetric comparison of photon stereotactic radiosurgery techniques (Gamma Knife vs. micromultileaf collimator linear accelerator) for acoustic neuroma–and potential clinical importance. Int J Radiat Oncol Biol Phys 57:1450–1459PubMedGoogle Scholar
  18. 18.
    Chopra R, Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC (2007) Long-term follow-up of acoustic schwannoma radiosurgery with marginal tumor doses of 12–13 Gy. Int J Radiat Oncol Biol Phys 68:845–851PubMedGoogle Scholar
  19. 19.
    Balasubramaniam A, Shannon P, Hodaie M, Laperriere N, Michaels H, Guha A (2007) Glioblastoma multiforme after stereotactic radiotherapy for acoustic neuroma: case report and review of the literature. Neuro Oncol 9:447–453CrossRefPubMedGoogle Scholar
  20. 20.
    Bari ME, Forster DM, Kemeny AA, Walton L, Hardy D, Anderson JR (2002) Malignancy in a vestibular schwannoma: report of a case with central neurofibromatosis, treated by both stereotactic radiosurgery and surgical excision, with a review of the literature. Br J Neurosurg 16:284–289CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2010

Authors and Affiliations

  • Manish Singh Sharma
    • 1
  • Rakesh Singh
    • 1
  • Shashank S. Kale
    • 1
  • Deepak Agrawal
    • 1
  • Bhawani Shankar Sharma
    • 1
  • Ashok Kumar Mahapatra
    • 1
  1. 1.Department of Neurosurgery and Gamma KnifeAll India Institute of Medical SciencesNew DelhiIndia

Personalised recommendations